HK1130439A1 - Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature - Google Patents

Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Info

Publication number
HK1130439A1
HK1130439A1 HK09110427.3A HK09110427A HK1130439A1 HK 1130439 A1 HK1130439 A1 HK 1130439A1 HK 09110427 A HK09110427 A HK 09110427A HK 1130439 A1 HK1130439 A1 HK 1130439A1
Authority
HK
Hong Kong
Prior art keywords
freeze
room temperature
pharmaceutical combination
vinca alkaloids
injectable pharmaceutical
Prior art date
Application number
HK09110427.3A
Other languages
English (en)
Inventor
Elie Leverd
Joel Bougaret
Marie-Dominique Ibarra
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38293420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1130439(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of HK1130439A1 publication Critical patent/HK1130439A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK09110427.3A 2006-12-29 2009-11-10 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature HK1130439A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0656044A FR2910812B1 (fr) 2006-12-29 2006-12-29 Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
US89705907P 2007-01-24 2007-01-24
PCT/EP2007/064612 WO2008080968A1 (en) 2006-12-29 2007-12-28 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Publications (1)

Publication Number Publication Date
HK1130439A1 true HK1130439A1 (en) 2009-12-31

Family

ID=38293420

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110427.3A HK1130439A1 (en) 2006-12-29 2009-11-10 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature

Country Status (24)

Country Link
US (1) US8304424B2 (xx)
EP (1) EP2120934B1 (xx)
JP (1) JP2010514737A (xx)
KR (1) KR20090097883A (xx)
CN (1) CN101534821B (xx)
AR (1) AR064715A1 (xx)
AU (1) AU2007341231B2 (xx)
BR (1) BRPI0722076A2 (xx)
CA (1) CA2673232A1 (xx)
CL (1) CL2007003838A1 (xx)
FR (1) FR2910812B1 (xx)
HK (1) HK1130439A1 (xx)
IL (1) IL199556A (xx)
MA (1) MA30892B1 (xx)
MX (1) MX2009006949A (xx)
NO (1) NO20092726L (xx)
NZ (1) NZ576583A (xx)
RU (1) RU2449791C2 (xx)
SA (1) SA07280720B1 (xx)
TN (1) TN2009000258A1 (xx)
TW (1) TWI415631B (xx)
UA (1) UA96977C2 (xx)
WO (1) WO2008080968A1 (xx)
ZA (1) ZA200903115B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102151249A (zh) * 2010-02-11 2011-08-17 石药集团中奇制药技术（石家庄）有限公司 一种长春氟宁的药用组合物
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102772373B (zh) * 2011-05-11 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用酒石酸长春瑞滨粉针剂及其制备方法
EP3843885A1 (en) * 2018-08-31 2021-07-07 FUJIFILM Irvine Scientific, Inc. Venting system for a mixing apparatus

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
JPH02290822A (ja) * 1989-04-04 1990-11-30 Eli Lilly & Co 医薬製剤
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
PL205936B1 (pl) * 2002-02-22 2010-06-30 Schering Corp Farmaceutyczny preparat zawierający termozolomid oraz sposób jego wytwarzania
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
CN103948545B (zh) * 2004-05-03 2017-10-03 益普生生物制药公司 用于药物输送的脂质体
ES2434944T5 (es) * 2005-03-14 2022-10-20 Wyeth Llc Composiciones de tigeciclina y procedimientos de preparación

Also Published As

Publication number Publication date
RU2009128327A (ru) 2011-02-10
TW200833369A (en) 2008-08-16
UA96977C2 (ru) 2011-12-26
MA30892B1 (fr) 2009-11-02
AR064715A1 (es) 2009-04-22
RU2449791C2 (ru) 2012-05-10
CN101534821A (zh) 2009-09-16
EP2120934B1 (en) 2014-05-07
EP2120934A1 (en) 2009-11-25
ZA200903115B (en) 2010-04-28
NO20092726L (no) 2009-07-20
FR2910812A1 (fr) 2008-07-04
NZ576583A (en) 2012-01-12
JP2010514737A (ja) 2010-05-06
IL199556A (en) 2014-09-30
KR20090097883A (ko) 2009-09-16
US8304424B2 (en) 2012-11-06
SA07280720B1 (ar) 2012-02-07
CL2007003838A1 (es) 2008-07-04
AU2007341231A1 (en) 2008-07-10
US20100087473A1 (en) 2010-04-08
TWI415631B (zh) 2013-11-21
AU2007341231B2 (en) 2013-03-21
CA2673232A1 (en) 2008-07-10
FR2910812B1 (fr) 2009-03-20
WO2008080968A1 (en) 2008-07-10
CN101534821B (zh) 2012-01-25
MX2009006949A (es) 2009-07-14
BRPI0722076A2 (pt) 2014-04-08
TN2009000258A1 (en) 2010-10-18

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
EP2078719A4 (en) COMPOUND WITH BICYCLIC PYRIMIDINE STRUCTURE AND THE COMPOUND CONTAINING PHARMACEUTICAL COMPOSITION
IL197451A (en) History of Phenylamino and 4-Phenylalkylamino Quinazoline and Pharmaceuticals Containing It
IL198591A0 (en) Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
EP1855750A4 (en) DEVICE FOR DELIVERING DRUG BY NEBULIZATION, WITH LATCH DETECTION AND TEMPERATURE PROTECTION
IL196601A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
ATE555791T1 (de) Pharmazeutische zusammensetzung enthaltend gestagene und/oder estrogene und 5-methyl-(6s)- tetrahydrofolat
IL193164A0 (en) Polymeric conjugates of 7-ethyl-10-hydroxycamptothecin and pharmaceutical compositions containing the same
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
IL199265A (en) Oxindol derivatives are converted and used to make a drug
IL188744A0 (en) High drug load formulations and dosage forms
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
EP1993590A4 (en) COMPOSITIONS AND METHODS FOR DELIVERY OF GDNF LIGAND FAMILY PROTEINS
IL192596A (en) Pharmaceutical preparations containing combinations of triazine derivatives and insulin secretion stimulants and their use in the preparation of medicines
HK1130439A1 (en) Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature
IL199168A (en) Indolysin derivatives and their use in the preparation of anti-diabetic drugs
PL1655026T3 (pl) Zawierające diacereinę i meloksikam stałe preparaty farmaceutyczne
EP2219640A4 (en) TAXAN DERIVATIVES LYOPHILIZED PHARMACEUTICAL COMPOSITION WITH IMPROVED RECONSTITUTION TIME AND METHOD OF MANUFACTURING THEREOF
GB0610090D0 (en) Particulate drug compositions and their uses
IL190771A0 (en) Compressed solid dosage forms with drugs of low solubility and process for making the same
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
IL184697A0 (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts
IL195639A0 (en) Tricyclic compound and pharmaceutical use thereof
HK1100352A1 (en) Solid medicament of oral administration and preparation thereof
EP2098513A4 (en) TRICYCLIC COMPOUND AND ITS PHARMACEUTICAL USE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151228